Sun Pharma Advanced Research Company informs about statement on deviation or variation

06 Nov 2023 Evaluate

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023, Sun Pharma Advanced Research Company has confirmed that there is no deviation or variation in the use of proceeds, from the objects stated in the explanatory statement to the resolution contained in the Notice dated May 12, 2021 of the extra-ordinary general meeting of the Company and /or the Private Placement Offer cum Application Letter dated June 08, 2021 for the Preferential Issue of the Company. A statement confirming that there is no deviation or variation in the utilisation of these proceeds, duly reviewed and approved by the Audit Committee at its meeting held today November 06, 2023, is enclosed.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

190.40 -5.70 (-2.91%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 847.55
Sagility India 28.27
AGS Transact Tech 79.58
Just Dial 1050.60
Krystal Integrated 638.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.